Brigland Pfeffer was playing with his siblings in the backyard of his San Diego home, just a few feet away from his mother, when he made a loud noise.
“I thought he was going to die. We all thought he was going to die,” Brigland’s mother, Lindsay Pfeffer, toldCBS8.
After calling 911, an ambulance took them to Palomar Medical Center Escondido, the closest medical facility that carried antivenom, located 25 minutes away from their home.
RELATED:
Image credits:dr.lindsay.pfeffer
The poison moved quickly through Brigland’s body. By the time they reached thehospital, the toddler’s hand was swollen and purple.
Unable to start an IV (intravenous therapy), themedical staffadministered the antivenom using a procedure called intraosseous vascular access, which delivers medicine into the bone marrow cavity.
The boy was then transferred to the pediatric intensive care unit at Rady Children’s Hospital, the largest children’s hospital on the West Coast, where he received more antivenom. In the end, it took 30 vials of antivenom to treat him.
“Nobody understands how he’s alive. This is unheard of why he actually made it,” Pfeffer said. “Because he’s 2, he’s more likely to die, but because he’s 2, he’s more likely to heal. But you have to survive to get there.”
The Pfeffers were charged a total of $297,461 for the treatment, which included two ambulance rides, an emergency room visit, and a couple of days in pediatric intensive care, according toKFF Health News.
Anavip, the antivenom used on the boy, accounts for $213,278.80 of the bill.
Lindsay Pfeffer, the boy’s mom, called 911 immediately after he heard his son scream and saw a rattlesnake, the largest venomous snake in the US
View this post on Instagram
Brigland’s family was charged two different prices for Anavip at the healthcare facilities.
Palomar Medical Center—the firsthospitalthe boy visited—charged $9,574.60 per vial, for a total of $95,746 for the first 10 doses of the antivenom.
Then, Rady Children’s Hospital charged $5,876.64 for each vial, totaling $117,532.80 for the 20 vials Brigland received there.
Medicare—the US government program for those with limited income and resources—pays about $2,000 for a vial of Anavip, which is the price hospitals pay for the antivenom, according to Stacie Dusetzina, a professor of health policy at Vanderbilt University Medical Center.
“Nobody understands how he’s alive. This is unheard of why he actually made it,” Lindsay said
Leslie Boyer, a doctor and toxicology researcher, broke down the cost of antivenom in a 2015 editorial published in theAmerican Journal of Medicine.
Boyer’s study reveals that the hefty price of antivenom in the US is not due to high manufacturing costs or the cost of the drug itself; instead, it appears to be the result of hospitals marking the product up to cover operational expenses and increase profits.
Gathering data from factory supervisors, animal managers, hospital pharmacists, and other sources, the doctor estimated the cost of a hypothetical antivenom at $14,624 per vial. (On average, a patient requires 18 vials to treat asnakebite, as perKFF Health News.)
Where does this figure come from? According to Boyer, the venom itself accounts for only 2 cents of the total. Manufacturing costs $9, and clinical trials account for $300 per vial.
But $10,250—over 70% of thetotal price—is attributable to hospital charges.
“By far the greatest contributor to final patient billing was the portion of hospital charges later discounted for contracted payers, a negotiated amount that varied widely among hospitals but that does not represent actual collections for the majority of patients,” the doctor wrote.
“This analysis demonstrates that well more than half of the astonishing hospital charges reported in the lay media are not true costs at all, but are instead attributable to the idiosyncrasies of the US healthcare finance system.”
Anavip, the antivenom used on the boy, accounts for $213,278.80 of the total medical bill
“All the parties benefit when the price rises. Hospitals and private insurance plans can mark up the prices to cover their many costs; middle players—who should be negotiating for lower prices—actually pocket more when the prices rise; and, of course, pharmaceutical companies make more when they can raise the prices, even after accounting for what the other players take out of the system.
“Patents and non-patent exclusivities (such as Orphan Drug Designation) help pharmaceutical companies extend protection of their drugs, a practice some call ‘life-cycle management’ and others call ‘evergreening.'”
Pharmaceutical companies may offer coupon programs for those who can’t afford a certain drug. However, Feldman points out that this is not a solution for emergency medications, as patients need treatment immediately.
“Companies can try to bargain with the hospital. Often, the hospital or others will negotiate. But families should beware. Aggressive hospitals or billers can dispatch aggressive debt collection agencies that can hound the family and ruin their credit.”
Some facilities provide care even if patients don’t have insurance, addedDr. Kenneth H. Schell, a pharmacy regulatory and compliance consultant and professor of Pharmacy Law and Ethics. In these cases, the cost is arranged between the healthcare facility and the patient.
“There are manufacturer programs and other methods to help the patient pay. In addition, if the patient meets certain criteria, State Medicaid programs can be employed,” Dr. Schell toldBored Panda.
“As a last resort, a facility may have a program for those who cannot pay. This ultimately results in the facility writing off the non-payment as bad debt. This results in some tax relief, but financially, this is not the best long term strategy for dealing with this issue.”
Nerve damage and scar tissue have left Brigland’s right thumb much weaker, and he is now left-handed
As not all emergency rooms carry antivenom, it’s recommended to go to a large hospital. Depending on the severity of the bite, initialtreatmentmay begin at an urgent care facility while arrangements are made for transfer to a hospital equipped to handlesnake bites.
Since being bitten in May, Brigland’s hand has healed, though nerve damage and scar tissue have left his right thumb much weaker. His family has installedsnakefencing around their yard.
Ultimately, Sharp Health Plan, the insurer covering thetoddler, negotiated down the charges for his treatment, and the family paid $7,200. However, this summer, Pfeffer received a letter indicating the family owes an additional $11,300 for one of the ambulance transports.
Bored Pandahas contacted LinsdayPfeffer for comment.
“We deserve and desperately need universal healthcare,” one reader exclaimed
You May LikePassengers Upset After Plane Makes Emergency Landing Due To “Serious Medical” Crisis On BoardKarina Babenok“Wish There Were More Like Him”: People’s Support For Luigi Grows After His First Public StatementRenan Duarte“Call Me Lazy”: Mother, 34, Stuns With Ozempic Transformation And Side EffectKarina Babenok
Karina Babenok
Renan Duarte
News
